|
Match
|
Document |
Document Title |
|
|
7361642 |
Canine specific growth hormone releasing hormone
A composition and a method of increasing growth hormone (“GH”) values in a canine or dog, and more specifically, a canine- or dog-specific growth hormone releasing hormone (“dGHRH”), or...
|
|
|
7338656 |
Composition and method to alter lean body mass and bone properties in a subject
A method for decreasing the body fat proportion, increasing lean body mass, increasing bone density, or improving the rate of bone healing, or all, of a subject. Embodiments of the invention...
|
|
|
7250405 |
Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
The intramuscular electroporated injection of a protease-resistant growth hormone-releasing hormone (“GHRH”) cDNA into rat dams at 16 days of gestation resulted in the enhanced long-term growth...
|
|
|
7241744 |
Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
The present invention pertains to compositions and methods for plasmid-mediated supplementation. The compositions and method are useful for retarding the growth of the tumor, and retarding...
|
|
|
7166461 |
Polynucleotides encoding a super-active porcine growth hormone releasing hormone analog
Inadequate growth due to deficiencies in growth hormone (GR), growth hormone releasing hormone (GHRH), or genetic diseases can be ameliorated utilizing recombinant protein therapy with a novel GHRH...
|
|
|
6551996 |
Super-active porcine growth hormone releasing hormone analog
Inadequate growth due to deficiencies in growth hormone (GR), growth hormone releasing hormone (GHRH), or genetic diseases can be ameliorated utilizing recombinant protein therapy with a novel GHRH...
|
|
|
6241965 |
Somatostatin derivatives and their radiolabelled products
This invention relates to therapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labelled radiodiagnostic agents. Specifically, the invention relates to...
|
|
|
6051206 |
Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled...
|
|
|
6017512 |
Radiolabeled peptides
This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled...
|
|
|
6008058 |
Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
A method of preparing cyclic peptide mixtures via side chain or backbone and solid phase synthesis. The cyclic peptide mixtures form libraries that are useful for screening purposes featuring the...
|
|
|
5734012 |
Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
This invention pertains to cyclic polypeptides having gastrointestinal motor stimulating activity which may be represented by formula (1): ##STR1## including optically active isomeric forms and the...
|
|
|
5677419 |
Cyclic vasoactive peptide analogs
Analogs of porcine Vasoactive Intestinal Peptide are disclosed. The analogs have been cyclized by the covalent attachment, via an amide bond, of the side-chain carboxy terminus of one amino acid in...
|
|
|
5620675 |
Radioactive peptides
This invention relates to therapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing label radiodiagnostic agents. Specifically, the invention relates to...
|
|
|
5493006 |
Cyclic CRF analogs
Improved CRF peptide antagonists have the formula: ##STR1## wherein R 20 is Cys or Glu; R 23 is Cys, Lys or Orn; provided that when R 20 is Cys, R 23 is Cys and when R 20 is Glu, R 23 is Lys...
|